[Skip to Content]
[Skip to Content Landing]

Metamorphopsia in a Middle-aged Man

Educational Objective
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
1 Credit CME

A 47-year-old man presented with gradual onset of blurry vision in both eyes for several months. Best-corrected visual acuity was 20/20 OD and 20/40 OS. Intraocular pressure was 23 mm Hg in both eyes and was more than 21 mm Hg in both eyes on multiple visits. Medical history included hypertension, obesity, left adrenalectomy, and pterygium excision surgery in the left eye. The patient denied previous episodes of blurry vision, history of corticosteroid use, sleep apnea, or type-A personality. Complete review of systems was otherwise negative. Amsler grid testing revealed paracentral metamorphopsia in both eyes. Extraocular motility, pupillary light reactions, and confrontational visual fields were normal. Slitlamp examination and gonioscopy results were normal in both eyes. An external photograph of the patient is shown in Figure 1A. Fluorescein angiography demonstrated multiple areas of late pinpoint leakage and patches of mottled hyperfluorescence in both eyes (Figure 1B).

Please finish quiz first before checking answer.

You answered correctly!

Read the answer below and download your certificate.

You answered incorrectly.

Read the discussion below and retake the quiz.

A 47-year-old man presented with gradual onset of blurry vision in both eyes for several months. Best-corrected visual acuity was 20/20 OD and 20/40 OS. Intraocular pressure was 23 mm Hg in both eyes and was more than 21 mm Hg in both eyes on multiple visits. Medical history included hypertension, obesity, left adrenalectomy, and pterygium excision surgery in the left eye. The patient denied previous episodes of blurry vision, history of corticosteroid use, sleep apnea, or type-A personality. Complete review of systems was otherwise negative. Amsler grid testing revealed paracentral metamorphopsia in both eyes. Extraocular motility, pupillary light reactions, and confrontational visual fields were normal. Slitlamp examination and gonioscopy results were normal in both eyes. An external photograph of the patient is shown in Figure 1A. Fluorescein angiography demonstrated multiple areas of late pinpoint leakage and patches of mottled hyperfluorescence in both eyes (Figure 1B).

Survey Complete!

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Jayanth Sridhar, MD, Bascom Palmer Eye Institute, 900 NW 17th St, Miami, FL 33136 (jsridhar1@med.miami.edu).

Published Online: July 15, 2021. doi:10.1001/jamaophthalmol.2020.7095

Conflict of Interest Disclosures: Dr Sridhar reported personal fees from Alcon, DORC, Oxurion, and Regeneron Pharmaceuticals. No other disclosures were reported.

Additional Contributions: We thank the patient for granting permission to publish this information.

References
1.
Isidori  AM , Graziadio  C , Paragliola  RM ,  et al; ABC Study Group.  The hypertension of Cushing’s syndrome.   J Hypertens. 2015;33(1):44-60.PubMedGoogle ScholarCrossref
2.
Li  D , El Kawkgi  OM , Henriquez  AF , Bancos  I .  Cardiovascular risk and mortality in patients with active and treated hypercortisolism.   Gland Surg. 2020;9(1):43-58.PubMedGoogle ScholarCrossref
3.
Habib  SN , Lin  Z , Puvanachandra  N .  Ocular hypertension secondary to high endogenous steroid load in Cushing’s disease.   BMJ Case Rep. 2019;12(1):bcr-2018-226738.PubMedGoogle Scholar
4.
Kersey  JP , Broadway  DC .  Corticosteroid-induced glaucoma: a review of the literature.   Eye (Lond). 2006;20(4):407-416.PubMedGoogle ScholarCrossref
5.
Chung  YR , Seo  EJ , Lew  HM , Lee  KH .  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy.   Eye (Lond). 2013;27(12):1339-1346.PubMedGoogle ScholarCrossref
6.
Ji  S , Wei  Y , Chen  J , Tang  S .  Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy.   Int J Clin Pharm. 2017;39(3):514-521.PubMedGoogle ScholarCrossref
7.
Lotery  A , Sivaprasad  S , O’Connell  A ,  et al; VICI trial investigators.  Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI).   Lancet. 2020;395(10220):294-303.PubMedGoogle ScholarCrossref
8.
Schwartz  R , Habot-Wilner  Z , Martinez  MR ,  et al.  Eplerenone for chronic central serous chorioretinopathy.   Acta Ophthalmol. 2017;95(7):e610-e618.PubMedGoogle ScholarCrossref
9.
Carvalho-Recchia  CA , Yannuzzi  LA , Negrão  S ,  et al.  Corticosteroids and central serous chorioretinopathy.   Ophthalmology. 2002;109(10):1834-1837.PubMedGoogle ScholarCrossref
10.
Bouzas  EA , Scott  MH , Mastorakos  G , Chrousos  GP , Kaiser-Kupfer  MI .  Central serous chorioretinopathy in endogenous hypercortisolism.   Arch Ophthalmol. 1993;111(9):1229-1233.PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close